-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OcaCN9QfJ88ALzk6vg0oi+fafoNztTxEe8QHUe1ZR11uMMA2fyFO1xjR8u36mYL1 c6T/FmeUbsFLsNEGFb61oA== 0001140361-07-016818.txt : 20070817 0001140361-07-016818.hdr.sgml : 20070817 20070817174647 ACCESSION NUMBER: 0001140361-07-016818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070815 FILED AS OF DATE: 20070817 DATE AS OF CHANGE: 20070817 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Savel Robert Michael II CENTRAL INDEX KEY: 0001394692 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 071066101 BUSINESS ADDRESS: BUSINESS PHONE: 707 761-4322 MAIL ADDRESS: STREET 1: 1025 OPAL WAY CITY: VACAVILLE STATE: CA ZIP: 95687 4 1 doc1.xml FORM 4 X0202 4 2007-08-15 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001394692 Savel Robert Michael II C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 SVP Technical Operations Stock Option (Right to Buy) 22.10 2007-08-15 4 A 0 10000 0 A 2014-08-15 Common Stock 10000 10000 D This option vests with respect to 1/48 of the shares per month over four years after August 15, 2007, the date of grant. Only vested options are exercisable. /s/ Francis Sarena by Francis Sarena, Attorney-in-Fact for Robert Savel 2007-08-17 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document
Power of Attorney
 
The undersigned, an officer of PDL BioPharma, Inc., a Delaware corporation (the “Company”), hereby constitutes and appoints Andrew Guggenhime and Francis Sarena, and each of them, for so long as such person is an employee of the Company, the undersigned’s true and lawful attorney-in-fact, with full power of substitution and resubstitution, each with the power to act alone for the undersigned and in the undersigned’s name, place and stead, to:
 
1.
Complete and execute Forms 3, 4 and 5 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and other forms and all amendments thereto on the undersigned’s behalf as such attorney-in-fact shall in his discretion determine to be required or advisable pursuant to Section 16 of the Exchange Act and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s beneficial ownership of securities of the Company or changes in such beneficial ownership; and
 
2.
Do all acts necessary in order to file such forms and amendments with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other persons or agencies as the attorney-in-fact shall deem appropriate.
 
The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with or liability under Section 16 of the Exchange Act or any rules and regulations promulgated thereunder or any successor laws and regulations.
 
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s beneficial ownership of securities of the Company or changes in such beneficial ownership, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.
 
The undersigned has executed this Power of Attorney as of ____June 18, 2007.
 

 
Signature:
 /S/ Robert M. Savel, II
   
Robert M. Savel, II
 
 


 -----END PRIVACY-ENHANCED MESSAGE-----